Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
Search Tags: HIV
The number of newly diagnosed HIV and AIDS cases in the District fell for the second straight year in 2009, but the nation's capital still faces an epidemic infection rate connected to the disease, a city report says.
Sunday will mark 30 years since the Centers for Disease Control and Prevention reported the first cases of the disease that would become known as AIDS.
Part 1 of an interview with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health
Part 2 of an interview with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health
The D.C. mayor has directed acting Attorney General Irvin Nathan to return the two SUVs City Council Chairman Kwame Brown ordered for himself.
DoD is on a mission to develop a preventive HIV vaccine for U.S. military personnel and for the global community.
Scientists led by the National Institutes of Health have discovered antibodies that will prevent most HIV strains from infecting human cells. Two potent human antibodies have been found to stop more than 90 percent of known global HIV strains from infecting human cells in the lab. Scientists have even demonstrated how one of the disease-fighting proteins is able to do it. They found the antibodies using a novel molecular device that homes in on the specific cells that make antibodies that fight HIV. According to the scientists, the antibodies could be used to design improved HIV vaccines, or could be further developed to prevent or treat HIV infection. Moreover, the method used to find the antibodies could be used to find therapeutic antibodies for other infectious diseases.